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Summary
A method is described that, on the basis of the time course of
amidolytic activity after the triggering of thrombin generation in
normal plasma, allows the calculation of the velocity of prothrom-
bin conversion independent of thrombin inactivating processes.
It is shown how the reaction constants for the o2M-dependent
and the o2M-independent thrombin inactivation processes can be
obtained in a sample of whole plasma.
The method is verified by demonstrating that the experimen-
tally observed time courses of residual prothrombin and of o2M-
thrombin complex coincide with those calculated from the time
course of amidolytic activity, and by showing that the course of
prothrombin conversion in plasma without ct2-macroglobulin or
AT III is adequately described if the u2M or AT Ill-dependent
breakdown constants are taken zero in the calculations.
It appears that the inactivation of thrombin, endogenously
generated in whole plasma, is about half as fast as that of
exogenous thrombin added to the plasma.
A computer program is presented that carries out the relevant
calculations.
lntroduction
The thrombin generation curve is one of the oldest tools of the
coagulation trade. It is the basis of the so-called two-stage
prothrombin estimation (I,2,3) but its roots go as far back as the
very discovery of prothrombin (a). The rise and fall of thrombin
concentration after triggering of.coagulation in plasma results
from the combined activity of the prothrombin activating enzyme
complex (prothrombinase) and the thrombin inactivating pro-
cesses, i. e. the binding of thrombin by antithrombins, such as
antithrombin III and o2-macroglobulin (5, 6).
The general shape of the curve shows a short lag time and a
fairly quick rise. After the maximum has been reached a gradual
decline is observed that, if the clotting of fibrinogen is used to
estimate thrombin, will eventually approach azerolevel. Because
the complex of a protease with o2-macroglobulin has a persistent
activity towards small molecular weight substrates (6-10) the final
level of activity will not be zero if the thrombin concentration is
determined with the aid of chromosenic substrates.
The classical thrombin generation test suffers from an impor-
tant drawback: the samples from the mixture in which thrombin is
generated have to be tested immediately on a fibrinogen contain-
ing reagent. Estimation of low concentrations of thrombin tends
to be very imprecise and time-consuming when clotting methods
are used. It therefore is virtually impossible to achieve in this way
a sampling pattern with enough measuring points and of sufficient
accuracy over the whole time range. A detailed analysis of the
thrombin generation curve obtained by this method is therefore
impossible.
This article describes a method to obtain thrombin generation
curves with sampling intervals that can be as small as 5 sec. The
thrombin is measured by its action on a chromogenic substrate. It
is shown how these curves can be used to compute the time course
of the process that generates thrombin (prothrombinase) inde-
pendently of the processes that inactivate thrombin (antithrom-
bins). These calculations can be carried out with the aid of a
personal computer.
The following abbrevations will be used: AT III : Antithrom-
bin III; u2M : o2-macroglobulin; Tiis : tris (hydroxymethyl)-
aminomethane; EDTA : Ethylenediamino tetracetate; SBTI :
Soybean Tiypsin Inhibitor.
Materials and Methods
Plasmas
Blood from healthy donors was collected on 0.13 M trisodium citrate;
nine parts of blood to one part of citrate solution.
A first and a second centrifugation were performed at 3,000 g, at 15' C
for 15 min. A third centrifugation was done at 4" C, for one hour at
23,000 g. The platelet free plasma thus obtained was stored at -80" C. It
was checked that the clotting factors and the antiproteases were in the
normal range. The clotting factors were determined according to refs. 11
and 12. Radial immuno diffusion was used to estimate o2-macroglobulin
and a1-antitrypsin (M. Partigen, Behring Werke, Germany). Antithrom-
bin III was determined according to ref. 13.
Defibrinated plasma was obtained by mixing an aliquot of plasma with
1:500 volume of a reptilase solution, letting a clot form for 10 min at
37" C and keeping the clotted plasma at 0" C for 10 min. The fibrin
formed was discarded by centrifugation (10 min, 5000 g, 0" C) or by
winding on a small plastic spatula. The concentrations of factors II, V,
VII, VIII, IX, X, XI, and XII did not significantly change by the reptilase
treatment. For the factors V and VIII series of dilutions (1 10%) of the
plasma before and after the treatment were compared. They showed
clotting times that were identical within the limits of experimental error
thus excluding the possibility that a combined effect of activation and
inactivation of the factors accidently mimicked as identical clotting
factors.
The euglobulin fraction from defibrinated plasma was obtained by acid
precipitation at low ionic strength as described in ref. 11. The precipitate
was dissolved in Michaelis buffer pH 7.35 containing 0.02 M trisodium
citrate, so as to obtain a concentration of the clotting factor II, V VII and
X that was not lower than 50%. No antithrombin activity could be
demonstrated in this mixture.
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Thrombin was formed in the euglobulin fraction by the addition of
human thromboplastin (1,:240 final diiution) and CaC12 (16 mM final
conc.). The development of thrombin activity was measured as described
later in this section.
Human brain thromboplastin was prepared as described in ref. 14. It
was subsequently centrifuged at 2000 g for 15 min and stored in 0.1 ml
aliquots at -20' C. It was thawed and incubated at 37" C for one hour,
then diluted as indicated with buffer A containing 100 mM of CaC12 and
kept at room temperature. In this way it remained stable for at least 4 h.
Reptilase was obtained from Laboratories Stago (Asnidres, France),
and prepared according to the indications of the manufacturet.
Soybean trypsin inhibitor (batch no 43 F-800) was obtained from
Sigma (St. Louis, USA). A 10 mg/ml solution in buffer A was used.
Staphylocoagulase was prepared as described in Hendrix et al. (15).
Chromogenic substrate for thrombin was H.D.-phe-pip-arg-pNA. 2 HCL
(52238, from Kabi, Sweden).
Other chemicals were the highest grade commercially available'
Buffers
A: 0.05 M Tiis-HCl, 0.1 M NaCl pH 7.5, with 0.5% egg albumin
(Sigma)
B: Buffer A with 20 mM EDTA.
I nhib ito r- D eficient P las mas
Plasma without o2M was obtained by addition of anti-o2M globulin to
normal plasma and elimination of the immunoprecipitate. The y-globulins
were isolated according to Steinbuch et ai. (16) from the serum of rabbits
immunized against purified human cr2M (gift from J. Tapon-Bretaudidre).
No o2M could be demonstrated by an immunoelectrophoretic method that
would detect o2M at concentrations )2"k of the normal plasma concentra-
tion. Plasma without AT III was prepared by gently stirring 2 ml of
normal human plasma with 0.8 mt of a slurry of sepharose to which anti
ATIII was bound (gift from Dr. Tian Huu Tii, Basel) for 18 h at 4" C.
The antithrombin activity in the plasma after adsorbtion was not
influenced by the addition of 1 U/ml of heparin.
Determination of the Time Course of Amidolytic Activity
An aliquot of plasma is defibrinated as indicated above. To 200 pl of
defibrinated plasma is added 50 pl of buffer A, that may contain the
substances of which the influence on thrombin generation has to be
invest igated (e.  g.  hepar ins) .
At zero time, thrombin generation is triggered by the addition of 50 pl
buffer A containing 100 mM of CaC12 and a suitable trigger of coagula-
tion. In the experiments described here human brain thromboplastin,
diiuted as indicated, was used as a trigger. If necessary the volumes
indicated may be proportionally altered. At fixed intervals (10, 15, 20, 30
or 60 sec) after zero time, a 10 pl aliquot of the mixture is added to a
disposable plastic microcuvette containing 465 pti of buffer B and 25 pl of
a 4 mM solution of S 2238 ar 37' C.
The aliquots are handled with a Microman pipette (Gilson, France). It
is essential to keep the plunger of the pipette down after subsampling and
to wipe the pipette tip carefully in order to avoid contamination of the
incubation mixtures with EDTA from the buffer in the cuvette. Plastic
tubes can be used instead of cuvettes but slass tubes adsorb thrombin and
give unpredictable results.
A 15 sec rhythm is easiiy managed, 10 sec intervals require some
practice. If shorter intewals are required one can make use of pipettes
equipped with a pushbutton connected to an input gate of a personai
computer (Apple IIe) programmed to record the moment of sampling.
After sampiing the cuvette is quickly and rigorously mixed on a Vortex
mixer. After 120 sec.the reaction in the cuvette is stopped by adding
0.3 ml of concentrated (98%) acetic acid, the cuvette is again thoroughly
mixed and can be kept at room temperature until reading. If a pushbutton
pipette and automatic time recording is used for sampling, then stopping
the reaction is also carried out with a time recording pipette.
The cuvettes are read at 405 nM in a suitable spectrophotometer
(LKB-Ultrospec). The generation of p-Nitroaniline was linear in time up
to an O.D. of 0.900. If necessary, incubation times longer or shorter than
two minutes can be used so as to obtain a suitable sensitivitv and not to
e r ceed  0 .9  O .D .
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The thrombin concentration data are processed by a computer
program to obtain the time course of prothrombin conversion velocity. A
full description of this procedure is to be found in the annexe.
Determination of the Thrombin Breakdown Constant
The same mixture as for thrombin generation curves is used, but with
a volume of 44 ttl of buffer A instead of 50 pl. After 2 to B min, at a
moment that sufficient thrombin is formed, 6 pl of SBTI solution (10 mg/
ml) is added to the main incubation mixture, so as to stop further
prothrombinase activity. SBTI at this concentration could be shown to
stop completely the activity of prothrombinase and not to influence the
amidolytic activity of thrombin (17).
At the shortest possible intervals after addition of the SBTI solution,
10 pl aliquots of the incubation mixture were added to cuvettes by the use
of a time recording pipette. The cuvettes were further treated as described
for  the thrombin generat ion curves.
Activ ation by S tap hy loco agulas e
A solution of staphylocoagulase of 50 nM is used. Of this solution
100 pl was added to 100 pl of a suitably diluted plasma sample. Normal
plasma can be diluted 1:50. The incubation mixture remaining after a
thrombin generation experiment is best diluted I :5 or 1:10. The thrombin
activity resulting from the formation of coagulase-thrombin is measured
by adding 10 pl of the. mixture to a cuvette containing buffer B and
chromogenic substrate as used for the thrombin generation curves. The
staphylocoagulase-prothrombin complex has the same molar activity
towards small molecular weight substrates as thrombin (15, 18). Commer-
cially available staphylocoagulase preparations can be used. In that case
the own amidolytic activity of the preparation should be determined and
its activating capacity has to be checked on normai pooled plasma.
Results
Experimental
The method that we propose here has the purpose to deter-
mine the velocity of prothrombin conversion in whole plasma. To
this end we determine the amidolytic activity that generates and
disappears in plasma after suitable triggering of the coagulation
process, using a substrate specific for thrombin. Then we analyse
the time-activity curve by a mathematical procedure that
separates the process of thrombin formation (prothrombinase
activity) and thrombin inactivation (antithrombin activity). In
order to carry out the calculations it is necessary to know the
Thble I Activities and concentrations of orM-thrombin and prothrombin
ln serum
Activities
(nM thrombin eq)
Concentrations
(nM)
Thromboplastin
dilution
o2M-T orM-T+SC o2M-T F II
(1)  (2)
40
100
200
400
10
4
4
10
r17 (+ 21
r23
109
111 (+ 5)
? 6 5  / +  5 )
280
273
266 (+ 8)
6s (+ 6; 148 (+ 5)
69 1s7
61, 162
62 (+ 11 iss ( i  e)
The activities were determined in the reaction mixtures of the
exper iments shown in Fig.  1,  between t  :  10 and t :20.  They are
expressed as the equivalent amount of thrombin that would give the same
rate of conversion of chromogenic substrate. orM-T (1) is the spontaneous
activity, orM-T * SC is the total activity that could be elicited by addition
of an excess of staphylocoagulase. a2M-T (2) ist the concentration of the
orM-thrombin complex obtained by multiplying the orM-T activity with
the relevant constant (f, see text). FII is the prothrombin concentration
obtained by subtraction of the first two colums. SEM are indicated when
n : 1 0
o  5  
T , M E  ( m i n . )
Fig. 1 Thrombin generation and the rate of thrombin formation in
normal plasma triggered with different dilutions of thromboplastin. The
reaction mixture consisted of 240 1l defibrinated plasma 60 pl buffer and
60 pl thromboplastin diluted as follows 1.1a0 (O);1/100 (A); 1/200 (f);
1/400 (O). The dotted lines represent the thrombin generation velocities
of the ll40 and 1/400 curves resp. The scale for these curves is the
thrombin generation velocity in nM.min-t
reaction constants of the breakdown processes. In the first part of
this section we will discuss how these data are obtained. In the
second part we verify the mathematical model.
I. The Thrombin Generation Curve and the Reaction Constants
Fig. 1 shows the thrombin activities generated in normal
plasma by different dilutions of tissue thromboplastin. As a rule
the standard derivation of each point is below 4o/" except for the
points located in the steep rising parts of the generation curve.
With the aid of pipettes provided with a signalling pushbutton
connected to an input port of an Apple IIe computer we could
estimate the experimental error in the sampling time to be
between 0.4 and 1 sec. In the horizontal parts of the curve the
coefficient of variation of the thrombin determination is 2.75oh.
When the tangent of the curve is steep, the time error adds
significantly to the overall error so as to make it 15-t8% at
tangents exceeding 1000 O.D.U. min-1. With the aid of the time
recording pipettes it is possible to eliminate the time error and to
obtain almost perfectly overlapping curves in repeated experi-
ments.
The amounts of residual prothrombin left in the mixtures after
the amidolytic activity has reached a steady end-level, were
determined with staphylocoagulase (Table 1). They are appar-
ently not dependent upon the variations in veiocity of thrombin
generation induced by dilution of thromboplastin.
From Fig.2 it appears that thrombin generation can be
resumed in the course of the experiment if purified human
prothrombin is again added. The method thus determines throm-
bin generation velocities that are dependent upon both prothrom-
bin concentration and prothrombinase activity.
Fig.3 shows experiments in which the breakdown constant of
thrombin in plasma was determined. The decay curve of thrombin
generated endogenously in plasma was obtained by stopping the
factor Xu activity in thrombin generating plasma by addition of
SBTI and measuring the thrombin disappearance (see methods
section). Alternatively 200 nM of thrombin that had been formed
in a euglobulin mixture was added at zeto time to defibrinated
plasma diluted in the same way as the reaction mixture, SBTI
included. In the latter case the decay was two fold quicker. The
slower decay of endogenously formed thrombin cannot be attri-
buted to ongoing thrombin formation because the amount of
prothrombin that can be demonstrated with staphylocoagulase in
the plasma does not change after the moment of stopping the
reaction with SBTI (results not shown). During the course of
thrombin generation the decay constant of thrombin does not
change (Fig. a), showing that in the course of the experiment
there is not a time-dependent change in the properties of
thrombin that could explain the difference in half-life time. For
the moment we have no explanation for this phenomenon (see
discussion).
The form of the decay curve is adequately described by a
Iogarithmic approach to a steady end level (Figs.3 and 4). From
experiments like these overall decay constants can be obtained.
This overall constant (k."n) is equal to the sum of the o2M-
=
:
o
I
F
1
g
:
-
=
@
E
I
F
.
2
o
=
o
F
0
o
5  1o  t t ue  (m  i n . )  t 5
Fig. 2 Effect of addition of prothrombin during thrombin generation. To
a thrombin generation experiment as in Fig. 1 (thromboplastin dilution
L/40) at1 min (arrow) 1500 nM of purified human prothrombin was added
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Flg. 3 Thrombin inactivation in plasma. A. (O-O) Decay of endogenous
amidolytic activity after addition of SBTI in a standard thrombin
generation experiment, 3 min after triggering the reaction with thrombo-
plastin 1/40. (O-O) The same data after subtraction of the steady end-
level of activity. B. (O-O) Decay of amidolytic activity of 200 nM
exogenous thrombin. (O-O) The same data after subtraction of the steady
end - l eve l  o f  ac t i v i t y
j , .  \  > . .\  \ ' . .
\
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Thble 2 Reaction constants of inactivation in orotease-inhibitor deficient
plasmas
Plasma Dil. R""-
o
-
z
@
=
F
k"ip
,  - ] \(mln '.1
k1
(mln ^.)
1,
^2
( m l n ' ,
Control 1.00 r.260 0.271 0.342 0.920
5
2
o2M def.
Control
0.78 0.733
i_o.as6-) 0.236 0.200 0.7330.756
AT III det
Control
0.45 0.249
0.630
0.1671) 0.082)
0.170 0.4600.270
1  5  
T r M E ( m i n . )
Fig.4 Decay of endogenous thrombin at different intervals after the start
of thrombin generation. In thrombin generation experiments triggered
with thromboplastin 1/40, SBTI was added at t : 3, 5 and 7 min. The
decay constants observed were 1.24,1.17 and 1.23 respectively. The data
are plotted on a log scale after subtraction of the steady end-levels
dependent decay constant (k1) and the non-o2M-dependent
constant (k2), mainly due to antithrombin III. Table 2 lists these
constants for various kinds of normal and deficient plasma. Also,
in this table the ratio of the amount of prothrombin consumed
during the experiment (i. e. the total amount of thrombin formed)
and the amount eventually taken up by o2M is given, as well as the
values of k1 and k2 that.can be calculated from these data. For this
calculation it is necessary to know the value of f; i. e. the ratio of
the amidolytic activity of one mole of the o2M-thrombin complex
to one mole of free thrombin. This value was obtained by
preparing thrombin in a euglobulin precipitate of defibrinated
plasma and estimating its activity. Then an excess of &rr o2rn€lcro-
0.240 0 . 1 1 1
Dil.: Dilution due to immunoadsorption, the control plasmas were
diluted to the same extent
k"*o:  Overal l  decay constant  observed (min I )
R"*o: Ratio of o2M-T to At III-T in the control plasma
kr and k2: Reudo first order reaction constants of the complexation of
thrombin wi th u2M and non-o2M respecl ively (min r)
1) Obtained from the double deficient plasma (accounting for the
difference in dilution)
2) Obtained by subtracting k1 from k."o
globulin preparation devoid of AT III activity was added and the
residual amidolytic activity was determined, f was estimated to be
0.558 + 0.043 (n : 10; S.E.M.) (cf. Table 1).
II. Verification of the Model
The adequacy of our model was tested in two fundamentally
different ways a) by comparing the time course of reaction
products as predicted by the model with those actually found, b)
by studying the effect of selective elimination of AT III and/or
ozM.
Double def. 0.32 0.058
Control 0.462
0.058
0.352
T  l M  E  ( m i n . )
Fig.5 Comparison of observed and computed levels of the o2M-
thrombin-complex. A standard thrombin generation experiment was
carried out. Thrombopiastin diluted 1:40 was used as a trigger. From the
amidolytic activity (O) the concentration of cr2M-T complex was computed
(O). The levels of orM-T complex found experimentally are represented
b v a
12
1 0  0 0
5 0 0
5  
r , u e ( r i n . l u
Fig.6 Comparison of observed and computed levels of consumed
prothrombin. In a standard thrombin generation experiment (trigger:
thromboplastin 1:40) the amount of prothrombin converted,(O) was
computed from the amidolytic activities (O) and compared to the
difference between the original amount of prothrombin and amount
remaining during the time course of activation (A)
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Fig.7 Course of amidolytic activity in o2-macroglobulin deficient
plasma. I-I Amidolytic activity in a2M deficient plasma. a-O
Amidolytic activity in control plasma. Dotted line: Thrombin generation
velocity calculated from the amidolytic activity curves. O: points obtained
from the orM deficient plasma. *: points obtained from the control
plasma. The constants used for calculation are given in Tabte 1
In Fig.5 two sets of experimental data are plotted. The overall
amidolytic activity as determined by our standard procedure (O)
and the level of o2M-thrombin (A). The latter was determined by
subsampling from the reaction mixture into a solution containing
an excess (1 U/ml) of heparin and 20 mM EDTA. In this mixture
the generation of thrombin stops immediately and, because the
half-life of thrombin is <10 sec, the residual activity measured
after 1.0-20 min is due to the amount of c,2M-bound thrombin that
was present at the moment of subsampling. From the data on
amidolytic activity, with the formulas derived from the mathemat-
ical model, one can also calculate the time course of the o2M-
thrombin concentration (O). From Fig.5 it is seen that the
calculated values and the values actually determined coincide
within the limits of experimental error. Fig. 6 also shows the
equivalence of a set of experimental and calculated concentra-
tions, viz. those of the total amounts of prothrombin converted
into thrombin. Experimentally these conientrations were deter-
mined by subsampling into a mixture containing 20 mM EDTA,
1 U/ml of heparin and 2pM of staphylocoagulase. In this mixture
prothrombin conversion into thrombin stops, the thrombin pre-
sent is inactivated by AT III and the prothrombin present
converts quickly (second order rate constant 3.3 x 106M 1s-1;
[12] into the amidolytically active prothrombin-staphylocoagulase
complex that is not inactivated by AT III. Thus one obtains the
amount of residual prothrombin (after subtraction of the activity
due to o2M-thrombin determined independently) while the
amount of prothrombin converted into thrombin is found by
subtraction from the starting level. The equivalence between the
concentrations found experimentally and those derived from the
amidolytic activity via the kinetic model is again satisfactory.
A different approach to test the validity of the model is shown
in Figs.7 and 8. Here the inactivation system of the plasma was
modified by selective immunoadsorbtion of o,2-macroglobulin and
AT III respectively. Control plasmas were obtained by treating
normal plasma in a comparable way with a gammaglobulin
fraction from serum from non-immunised rabbits and adjustment
of the dilution if necessary.
In Thble 2 it is shown that the decay constants calculated for
the non-deficient plasma are identical to those found experimen-
tally in the deficient plasmas, if one allows for a small amount of
inhibition that is due to neither o2M or AT III.
In Fig.7 the thrombin activity curves obtained with the u,2M
deficient plasma and its control are shown as well as the thrombin
generation velocity curves obtained from them, using the relevant
constants from Table 2. InFig.8 the same is done for the AT III
deficient plasma. In both Fig.7 and Fig. 8 the thrombin genera-
tion velocity curves obtained with the deficient and the control
plasmas superimpose within the limits of experimental error, as
would be expected from the model.
Discussion
For the study of the mechanism of thrombin formation in
plasma the two classical methods of enzymology are open, kinetic
4 0 0
3 0 0
2 0 0
Flg. B. Course of amidolytic activity in AT III defi-
cient plasma. 
 
--* 
 Amidolytic activity in AT III
deficient plasma. *---* Amidolytic activity in 1 o o
control plasma. Drawn line: Thrombin generation
velocity calculated from the amidolytic activity
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plasma. O: points obtained from the control plasma.
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analysis and isolation of enzymes with partial reconstruction of
the system form its components. In the last ten years the latter
approach has yielded important results and the main mechanisms
of activation of clotting factors are well known by now. It remains
difficult however to answer in this way questions about the
relative physiological importance of mechanisms that have been
shown to be biochemically possible. What is the importance ln
vivo of the extrinsic activation of factor IX? or of the feedback
activation of factors V and VIII by thrombin? The question of
whether heparin and its derivates inhibit the formation of
thrombin in vivo or only accelerate its inactivation is not settled
either. As a first step to approach the in vivo situation we
developed a method in which the generation of thrombin in whole
plasma ("ex vivo") can be studied independently of its breakdown
by antiproteases.
The method consists of measuring the course of amidolytic
activity after triggering thrombin formation in a sample of
defibrinated plasma and then eliminating the effect of the
breakdown processes by compensating for their velocities, that
are calculated from the concentration of thrombin and the
breakdown constants. The calculations are easily carried out on a
personal computer.
The problem with this approach is that the acceptability of the
results obtained is entirely dependent upon the acceptability of
the model and the mathematical procedure. Therefore it is
important to test extensively the validity of the method.
We assume that the situation in the plasma when thrombin
generates can be depicted by the following diagram:
prothrombinase
l k '
' prothrombin -+ thrombin --+ cr2M-thrombin
inactive,*"T0,'
The assumptions at the basis of the kinetic model are:
1. Thrombin breakdown occurs via two processes, one (caused by
AT III and others antiproteases) leading to inactive products,
the other (o2M-dependent) leading to a product with a residual
amidolytic activity.
2. Both reactions are of pseudo first order with regard to
th rombin .
It has been demonstrated that the interaction of AT III with
thrombin is a bimolecular reaction and shows second order
kinetics (I9,20). Under the conditions prevailing in our experi-
ments there is at least a ten-fold excess of AT III over free
thrombin and the excess of a.1-antithrombin is a hundred-fold. It
therefore seemed reasonable to try whether a model for this
reaction based on pseudo first order kinetics would stand verifica_
tion. The case of o2M-dependent inactivation is more complex.
Here the stoichiometry of the reaction is variable and the kinetics
of the reaction are complicated (20, 6-10), yet second order
reaction kinetics describe the situation if the o2M to thrombin
ratio is higher than 2 ro 1 (20). The initial concentration of o2M is
2 pM. No more than 300 nM of this is complexed in the course of
the experiment (Figs. 1 and 5). As a fiist approximation we
therefore again assumed pseudo first order kinetics. If, or to what
extent it is indeed an adequate description of this situation must
follow from the experiments.
The translation of the reaction model into rate equations, the
solution of these equations and their utilization in a computer
program is a technical problem in mathematics, that is explained
in the annexe and will not be discussed here.
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The following qualitative arguments support the correctness of
the model:
a. The partition between the AT III-II" complex and the o2M-
IIu complex of the thrombin generated in an experiment is
independent of the course of thrombin generation. This can be
seen in Fig. 1 and Table 1, where the total amount of prothrombin.
as well as the levels of o2M-IIu eventually obtained are indepen_
dent of the dilution of thromboplastin used. Our model pr"di.t,
such behaviour (formula 8).
b. The decay of thrombin activity is characterized by a
logarithmic approach to a steady end-level (Fig.3). This proves
the pseudo first order character of the breakdown constants(formula 4c).
c. The breakdown constant of thrombin does not change over
the experiment (Fig. 4).
d. The level of activity remaining in the plasma after activation
is explained by the level of o2M-IIu present (Fig. 5), in the absence
of o2M, the activity approaches the zero level (Fig.7).
In the absence of both o,2M and AT III there is a residual
antithrombin activity of about 18% of the total (Thble 2). This
activity is not heparin dependent and consumes thrombin in a
pseudo first order process (results not shown). In our formulas
this decay is included in the AT III dependent decay (k2). This
inhibition activity is presumably due to tr1 antitrypsin and other
antiproteases.
From the observations (a to d) it can be concluded that the
qualitative features of our model are supported by the experi-
ments. The validity of our model is further corroborated by the
similarity of the concentration courses calculated and those
actually observed. In principle the time courses of all the reactants
can be computed from the time course of the amidolvtic activitv.
In practise the amounts of remaining prothrombin and of the
a2M-thrombin complex can be determined independent of
amidolytic activity, thus offering the opportunity to compare the
results of the calculation with the time-course of concentrations
actually found. Figs.5 and 6 shows that the observed and the
computed points seem to follow the same curve.
Further qualitative arguments for the correctness of our
procedure can be derived from Figs.7 and 8. Here it is seen that
the velocities of thrombin generation computed from plasma -
specifically deficient in either o2M or in AT III coincidi with
those of the control plasma if the respective breakdown constants
are eliminated from the computation.
We conclude that, within the limits of experimental error our
model gives a satisfactory description of the situation in plasma
and that our procedure can be used to obtain thrombin seneration
velocities from amidolytic activities. The use of the computer in
this procedure is not unlike that of the microscope in that it can
reveal experimental features not apparent at direct inspection.
Several observations await explanation:
1. The lag time always observed when thromboplastin is used
as a trigger. It has to be determined whether feedback activations
by thrombin of factor V and/or VIII contribute to this process.
2. The difference in breakdown velocity of endogenously
generated thrombin and of exogenous thromtin. The ge'neration
of meizothrombin (21, 17) or any other amidolytic thrombin
precursor with a low affinity to antiproteases does not offer an
explanation because it would, in the course of the experiment;
convert into thrombin, so that the apparent decay constant found
would increase during the experiment and approach that of free
thrombin, which it does not (Fig. a). One can surmise that part of
the freshly formed thrombin is inaccessible to antiprotease action
because it still interacts with elements of the prothrombinase
complex and/or its own activation peptides. The itrong noncova-
lent interactions between the N terminal half of prothrombin(fragment 'J.,2) and the C terminal half (prethrombin 2, thrombin)
(22) make such interactioirs not a priori unlikely. This problem is
at present under investigation. The same phenomenon probably
explains why the pseudo order rate constants that we find for
endogenous thrombin,breakdown in whole plasma are below the
lower limits of ranges found in the literature with free thrombin
and in (partly) purified systems. For o2M we found 0.342 min-I
(Table 1) compared to 0.4-0.8 min-'in the literature. For AT III
the value was 0.920 min-1 compared to 1.4-3.6 min-1 (6-10, 23).
The value of 0.09 for the decay constant of thrombin in the
presence of the normal plasma concentration of o2M that can be
calculated from ref. 20, has been supposed by others to be based
on an underestimation of the second order rate constant of this
inhibit ion (10).
3. The model behaves as if the inhibitory capacity of o2M is
immediately available, although it is known that this molecule has
to be activated by a proteolytic enzyme, e.g. by the proteolytic
enzyme that it will complex with (5, 6 and references therein).
4. Even though prothrombinase is not exhausted (Fig.2), the
reaction comes to a stop when 5-I0% of the original prothrombin
is left. This suggests the possibility of product inhibition of
prothrombin activation in whole plasma. Our results indicate that
in 2:3 diluted normal platelet free plasma- (our standard system)
the pseudo first order rate constant of o2M, AT III and non-o2M-
non-ATIII antiproteases contribute 23%, 64% and 13% to the
overall disappearance rate of endogenous thrombin. This is in
accordance with the 20-30% of plasma antithrombin activity
assigned to a2M by several authors (10, 19,20).
We think that our method may be a valuable means to
investigate the physiology of thrombin generation in whole
plasma and to study the influence of antithrombotic drugs on, as
well as the pathological changes of this process. In the latter case
additional studies, such as the estimation of prothrombin activa-
tion peptides may be necessary.
The procedure we propose can also be applied to the study of
the factor X generating enzyme (Factor IXu - Factor VIII^ -
Phospholipid) in plasma on basis of the factor Xu levels observed.
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Annexe
Mathematical Analysis of the Thrombin Generation Curve
(G.M.Wi l lems,  H.  C.  Hemker ) .
The amidolytic activity that we observe in the experiment is the
sum of the activities of free thrombin and o2M-bound thrombin.
The experimental procedure gives this activity at a series of points
in time. It is our purpose to obtain the velocity of thrombin
generation alone as a function of time [g(t)], independent of the
breakdown processes.
We can make no assumptions as to the form of g(t) because the
enzyme that causes prothrombin activation (prothrombinase)
itself increases and decreases as an unknown function of time. We
describe the disappearance of thrombin as the sum of two pseudo
first order reactions, one giving the inactive product of the
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interaction of antithrombin III and thrombin (AT III-T) and
minor amounts of other inactive forms of thrombin and the other
the amidolytically active complex of o2-macroglobulin and throm-
bin (o2M-T). (see discussion for experimental justification).
The chemical model can be represented by a set of differential
equations that describes the relations between the reaction
velocities and the concentrations of the reactants in the svstem.
We will use the following symbols:
A(t) : amidolytic activity found at time t
P(t) : prothrombin concentration at time t
T(t) : thrombin concentration at time t
M(t) : o.2M-thrombin concentration at time t
g(t) : thrombin generation from prothrombin as a function of
time
A(t)  :  !  s (k,+kd(t- ' ,*r  {E:,  t tO[r-"  
ru '*o,r t , -o]*r fr) ]
(4a)
for t -+ o this gives
a t * l  :  r {  o ' ,  , , r ,  +  t t t s l }
(  K 1  - i K 2  )
(4b)
k1 : pseudo first order rate constant for
thrombin to o2M
k2 : pseudo first order rate constant for
thrombin to AT III
f : the ratio of the.enzymatic activity of one mole of o2M-T
over that of one mole of thrombin
The subcripts thr and mcr will indicate the activities due to
thrombin and to o2M-thrombin respectively, the total activity is
unsubscripted.
The amidolytic activity will be expressed in thrombin equiva-
lent-amounts, so that A : T in a solution containing only
thrombin and A : f.M in the presence of o2M-thrombin only.
At any moment the net velocity of thrombin formation will be
equal to the sum of the velocity of thrombin generation from
prothrombin and the velocity of thrombin breakdown:
d
_ 
r(t) : g(Q - k1r(t) - kzrft) (r[o] : o) (1u)
ot
The velocity of the formation of o2M-thrombin is proportional
to the concentration of free thrombin.
so that
log[A(t) - A(*)] :  tor{ t t ' t) l ' ,*u' }t ,-tu,+k)(t-s) (4")
I  K 1 + K 2  )
from which it follows that k1 + k2 can be obtained from the slope
of the plot of log [A(t)-A(o)] against ime. The activity found at
some late point(s) in the time curve are taken as A(m). In order to
obtain kr and k2 separately we integrate (2):
i -  ( l - I )k ,+k,
P ( o ) - P ( * ) :  J  g ( r ) d ( r ) d r : { ( o ) +  ; , .  
' A ( - )
r K r (s)
from which it follows that:
I k , ? f k ,  I l
A ( * ) :  j g ( r ) d r :  l P ( o ) - P ( r c ) l  ( 6 )K r + K 2  r o  K 1 - F K 2  |  I
where P(m) is the amount of prothrombin present after the
activation is over, so that P(o)-P(o) is the total amount of
thrombin that has been formed during the experiment from
formula (6), and equal to the amount of prothrombin converted
during the experiment. We calculate k1 as
1 . -A l -
(k l+k2)A(* )
f [P(o)-P(m)]
and k2 from:
ku: (kr + k2) -k1 (8)
Once the constants f, k1 and k2 are known we can use the
following rearrangement of formula 2 to ca{culate g(t):
g(t)dt : A(t) + (k1+ k2) - f  
. k1
k 1 + k 2
In practice A(n) is obtained at a series of times, t(n); n being
the running number of the observation. The integral in the right
hand term of formula (9) tt(n)] can be obtained as the area under
the curve generated by plotting
s(n) :  A(n)etk' .(n) (10)
against t(n), so that
n T  I
I ( n ) : ' 7 .  ) l ( t t n l - t ( n - 1 ) ) . ( s ( n ) + s ( n - 1 ) )  |  ( 1 1 )
: t  I
The amount of thrombin that would have been formed at the
moment of observation if no inactivation had taken place then is
obtained as:
T( " )  :  A(n)  +  [ (k1+k2- fk r ) / (k1+k2) ] .e - rk '  t (n ) . I (n )  (12)
The following series of Basic commands, operating on the
arrays A (n) and t(n) carries out these calculations.
100 CE : F * K1 : CT : (K1 + K2 - CEy(K1 + K2)
110A (0)  :  a  ;T  (s )  :  s  :  IN  :  0  :  SN :  0
120 FOR N : 1 TO E : REM E : number of data ooints
130 S : A(N) - EXP ICE. T (N)]
the binding of
the binding of
(7)
and the activity measured is the sum of the activities of thrombin
and s,M-thrombin:
A(t ) :  r ( t )+fM(o
These equations have the solution
In order to use this formula we need estimates of k1, k2 and f
separately. The value f can be obtained by comparing the
amidolytic activity of thrombin with that of o2M-thrombin (see
experimental section). If, at any moment s during thrombin
generation we stop the conversion of prothrombin (e. g. by the
addition of SBTI) then the course of the remaining activity is
siven bv:
d
dt M(0: k'r(t) (M[o] : o)
Au
,  T(r)  :  -  (kr+ k2)T(r) :  T(r)  :  Iclt
d
, 
M(t) :  kr T(t):  M(s) :  x4.
OI
(1b )
l
I(1c)  |
b
t
t u , +  f  ^  r + , , ,
e ^  J A ( t ) e - " ' c l r
o (e)
c(r): +{ A(t) + [(1-0k1+k,] j" " 'u',o1r;0,] (2)O l l  u
(3 a)
(3b)
A(t) : r(t) +fM(r) (3c)
where t is counted from moment s on and M, in the amount of
o2M-thrombin present at moment s.
From the formulas 3 it can be derived that:
1.6
1.40r: rN + [r(N) - r(N-1)] . [(s + sN)y2
150 TT(N) : A(N) + CT * I * EXP [- CE . T(N)]
160 v (N-1) : [rr(N) - rr(N-1)]/[r(N) - r(N-1)]
1 7 0 S N : S : I N : I
180 NEXT N
It will yield the array TT(N) and V(N) that, when plotted
against T(N) (sampling time) give the total amount of prothrom-
bin activated and the velocitv of prothrombin conversion as a
function of time.
This routine is the core of the program "Thrombinoscope" (24)
that a) stores the experimental data on disk b) calculates
prothrombinase activity c) stores the results of the calculation on
disk and d) displays the data and results in graphic and/or
alphanumeric format on the monitor or the printer. The program
was developed in Applesoft Basic on an Apple IIe personal
computer with 128 k RAM and Applesoft in ROM. Both data
obtained at regular and at irregular intervals can be accomodated.
It also contains the subprogram "Stopwatch" that is used to
record sampling and stopping times from pipettes provided with a
pushbutton. The program can be obtained from the authors.
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